A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomibAzmi Yerlikaya, Bircan Savran|Oncology Letters|2016Cited by 22
An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell lineAzmi Yerlikaya, Emrah Okur|Cytotechnology|2019Cited by 13